These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 11554912)
1. Post-infectious ophtalmoparesis associated with anti-GM1 but not with anti-GQ1b antibodies. Lavallée P; Vidailhet M; Dussaule JC; Derkinderen P Eur J Neurol; 2001 Sep; 8(5):475-6. PubMed ID: 11554912 [TBL] [Abstract][Full Text] [Related]
2. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies]. Tagawa Y; Matsumoto Y; Yuki N No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308 [TBL] [Abstract][Full Text] [Related]
3. Electrodiagnostic findings related to anti-GM1 and anti-GQ1b antibodies in Guillain-Barré syndrome. Jacobs BC; Meulstee J; van Doorn PA; van der Meché FG Muscle Nerve; 1997 Apr; 20(4):446-52. PubMed ID: 9121502 [TBL] [Abstract][Full Text] [Related]
4. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes. Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994 [TBL] [Abstract][Full Text] [Related]
5. Acute ophthalmoparesis associated with anti-GM1, anti-GD1a, and anti-GD1b antibodies after enterovirus infection in a 6-year-old girl. Fusco C; Bertani G; Scarano A; Giustina ED J Child Neurol; 2007 Apr; 22(4):432-4. PubMed ID: 17621523 [TBL] [Abstract][Full Text] [Related]
6. Anti-GM1 antibodies: the cause of otherwise unexplained ophthalmoplegias? Kowal L; Gajus MA; Kornberg AJ Clin Exp Ophthalmol; 2004 Aug; 32(4):411-4. PubMed ID: 15281977 [TBL] [Abstract][Full Text] [Related]
7. [Antibodies to GM1 and GQ1b gangliosides]. Obayashi H; Saida T; Fukui M; Hasegawa G; Nakamura N; Yoshikawa T Nihon Rinsho; 2005 Jul; 63 Suppl 7():653-5. PubMed ID: 16111360 [No Abstract] [Full Text] [Related]
15. [Antibodies to GM1 and GQ1b gangliosides]. Obayashi H; Fujinami A; Ohta M Nihon Rinsho; 2010 Jun; 68 Suppl 6():645-7. PubMed ID: 20942153 [No Abstract] [Full Text] [Related]
16. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes]. Akiyama M; Koga M; Yoshino H; Hamaoka A; Noguchi Y; Hirata K; Yuki N No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515 [TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. Willison HJ; Veitch J J Neuroimmunol; 1994 Mar; 50(2):159-65. PubMed ID: 8120137 [TBL] [Abstract][Full Text] [Related]
18. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome. Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105 [TBL] [Abstract][Full Text] [Related]
19. Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Kusunoki S; Chiba A; Kanazawa I Muscle Nerve; 1999 Aug; 22(8):1071-4. PubMed ID: 10417789 [TBL] [Abstract][Full Text] [Related]
20. Acute ophthalmoparesis in the anti-GQ1b antibody syndrome: electrophysiological evidence of neuromuscular transmission defect in the orbicularis oculi. Lo YL; Chan LL; Pan A; Ratnagopal P J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):436-40. PubMed ID: 14966161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]